Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use

Abstract

Nilotinib is an analog of imatinib increasingly used for the treatment of imatinib-resistant chronic myeloid leukemia. It has been considered a well-tolerated drug with little side effects. The most common adverse effects to nilotinib are skin rash, pruritus, headache, nausea, and fatigue. Nilotinib-induced vascular events are rare, including peripheral artery occlusive disease, Raynaud syndrome, cerebrovascular accidents. Myocardial infarction has rarely been reported. In this paper, we describe the case of a 37-year-old female who developed a severe myocardial infarction after nilotinib use. There are two different vascular events reported with nilotinib: A progressively worsening of preexistent occluding vascular lesions and vasospastic events. In our patient, myocardial infarction seems to be secondary to severe coronary occlusive event. Nilotinib might facilitate the development of vascular events in patients with preexisting risk factors. However several patients have been shown to experience such events in the absence of any cardiovascular risk factor. The mechanism of nilotinib-induced myocardial infarction is still controversial. It is reported to be induced via mitochondrial damage, a negative effect of the substance on pre-existing atherosclerotic changes or ischaemic processes. Our report emphasizes the importance of early detection and evaluation of cardiotoxicity in order to prevent fatal consequences of such an adverse event even in young patients.

Authors and Affiliations

Neila Fathallah, Kmira Zahra, Rania Bouneb, Mohamed Mahjoub, Wafa Guetari, Monia Zaier, Chaker Ben Salem, Abderrahim Khelif

Keywords

Related Articles

Parathyroid Adenoma in a Patient with Left Hip Pain: A Case Report

Diagnosis of primary hyperparathyroidism (PHPT) is a challenging issue in some cases because of the uncommon and various presentations. Primary hyperparathyroidism is a relatively common condition, originating from parat...

Sickle Cell Thalassemia: A Case Report and Review of Literature

Sickle cell disease is a single gene disorder causing a debilitating systemic syndrome characterized by chronic anaemia, acute painful episodes, organ infarction and chronic organ damage and by a significant reduction in...

Colonoscopy-induced Enteropathogenic Escherichia coli Bacteremia Diagnosed by Serum Polymerase Chain Reaction Method

We report the case of colonoscopy induced enteropathogenic Escherichia coli (EPEC) bacteremia by bacterial translocation. A 58-year old woman who complained of abdominal pain was performed colonoscopy. Intestinal mucosal...

Functional Massage of the Teres Major Muscle in Patients with Subacromial Impingement Syndrome. A Randomized Controlled Case Series Study

Aims: Subacromial impingement syndrome is the most common shoulder condition. Myofascial trigger points in teres major muscle can be associated with this syndrome. Our objective is to determine whether adding manual ther...

A Large Solid Pseudopapillary Tumour of the Body and Tail of Pancreas: A Rare Entity Treated with Combined Modality

Solid Pseudopapillary Tumour (SPPT) of the pancreas are rare tumours, accounting for only 1-2% of all pancreatic neoplasms. Increased rate of detection of this neoplasm in the last three decades is probably due to the in...

Download PDF file
  • EP ID EP327721
  • DOI 10.9734/IJMPCR/2016/28909
  • Views 90
  • Downloads 0

How To Cite

Neila Fathallah, Kmira Zahra, Rania Bouneb, Mohamed Mahjoub, Wafa Guetari, Monia Zaier, Chaker Ben Salem, Abderrahim Khelif (2016). Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use. International Journal of Medical and Pharmaceutical Case Reports, 7(5), 1-5. https://europub.co.uk/articles/-A-327721